Navigation Links
3 Common Drugs Trigger Most ER Visits by Seniors
Date:12/4/2007

Warfarin, insulin and digoxin account for a third of drug-related ER trips, study says

TUESDAY, Dec. 4 (HealthDay News) -- Side effects from just three drugs are responsible for a full third of all U.S. emergency room visits by senior citizens who had adverse reactions to medications, a new study found.

In 2004 and 2005, the blood thinner warfarin, the diabetes drug insulin and the heart drug digoxin caused about 58,000 emergency room visits a year in those 65 and older, the researchers found.

The major problem is that it's hard to determine the correct dose for each drug, said study lead author Dr. Daniel Budnitz, a medical officer with the U.S. Centers for Disease Control and Prevention (CDC).

"It's challenging," he said, "and it takes work between the patient and physician to get the dose just right."

Budnitz and his colleagues undertook the study to determine the danger posed to senor citizens by a long list of drugs that have been deemed "potentially inappropriate" for use in the elderly.

The researchers looked at several surveys of emergency room visits from 2004 and 2005. The study findings are published in the Dec. 4 issue of the Annals of Internal Medicine.

Forty-one drugs are on the list -- called the BEERS criteria -- of medications considered inappropriate for the elderly. But they accounted for just 3.6 percent of a total of about 177,000 annual emergency room visits.

Warfarin (also known as Coumadin), insulin and digoxin (which has a number of trade names) posed many more problems. (Digoxin is also on the list of potentially inappropriate drugs for the elderly, but it's only listed as a potential problem if taken in certain situations.)

All three medications are well-known, commonly used drugs and all can create problems in some cases.

Warfarin, often prescribed to heart patients, prevents blood clots by thinning the blood, but can cause excessive bleeding if the blood becomes too thin. Insulin treats diabetes but can sometimes cause blood sugar levels to drop to dangerous levels. And digoxin, a long-used drug, can cause a variety of problems from nausea to erratic heartbeats.

In some cases, there aren't good alternatives to these three drugs, although some doctors consider digoxin to have outlived its usefulness, the study authors noted.

Doctors can monitor the levels of all three drugs with blood tests, Budnitz said. Simple finger-prick blood tests allow testing of blood sugar levels, and similar tests measuring clotting ability are now available in some clinics for people taking warfarin, he said.

The study results are "a reminder that doctors and patients need to work on doing the best job we can managing these medicines," Budnitz said. "The answer isn't to take away medications."

Dr. Knight Steel, head of geriatric medicine at Hackensack University Medical Center in New Jersey, said the study results aren't really surprising. Doctors have long known the risks of the three drugs in question, he said, adding that the research doesn't provide any new information.

More information

To learn more about the health risks that drugs can pose to the elderly, visit Duke University Health System.



SOURCES: Daniel Budnitz, M.D., medical officer, U.S. Centers for Disease Control and Prevention, Atlanta; Knight Steel, M.D., chief of geriatrics, Hackensack University Medical Center, New Jersey; Dec. 4, 2007, Annals of Internal Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. UK junior doctors gaining less experience of common procedures
2. New insights into common knee injuries
3. High and mighty: first common height gene identified by researchers behind obesity gene finding
4. Figure Skater Peggy Fleming, HealthSaver Says: Take Pains For Back Strains, 2nd Most Common Doctor Complaint
5. Exelixis Commences Public Offering of Common Stock
6. Common misdiagnosis: most women believe they have a yeast infection when they dont
7. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
8. New Expert Report Dispels Common Myths About Aspartame
9. Common Foot Myths Trip Us Up
10. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
11. Allergy-Induced Asthma More Common in Affluent Countries
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
3 Common Drugs Trigger Most ER Visits by Seniors
(Date:8/19/2017)... MD (PRWEB) , ... August 18, 2017 , ... ... and Drug Administration Reauthorization Act of 2017, legislation that provides for greater public ... mild to moderate hearing loss to access OTC hearing aids without being seen ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... Curl Keeper® ... of NaturallyCurly.com® The Curl Leaders, Editors’ Choice 2017 Award for the second year in ... for hair stylists and curlies alike was voted Best Moisturizer for Type 2 Wavies ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/19/2017)... ... 2017 , ... Physician Partners of America Pain Relief Group ... pain management physician. He brings a wealth of pain management experience including a ... experience in spinal cord stimulation for chronic pain. , Dr. Ahmed earned his ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. ... presided over the Amazing Thailand Health and Wellness Tourism Showcase 2017 yesterday, which ... Pakprot, Deputy Governor for Tourism Products and Business at TAT said, “Thailand has ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)...   Mostyn Law and Gulf Coast Regional Blood Center ... . The Mostyn Law family has had 3 members ... why Mostyn Law is partnering with Gulf Coast Regional ... appreciation. Blood supplies are running low. Gulf Coast Regional ... needs in August. That is why the blood center reached out ...
(Date:8/14/2017)... TIKVAH, Israel , Aug. 15, 2017 ... developer of adult stem cell technologies for neurodegenerative diseases, ... 30, 2017. "We ... pivotal Phase 3 trial to investigate NurOwn ® ... Chief Executive Officer of BrainStorm. "We have agreements with ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
Breaking Medicine Technology: